These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16523929)

  • 41. Familial juvenile hyperuricemic nephropathy 1 (FJHN1).
    Bhargava R; Saigal R; Sharma R; Goyal L; Agrawal A
    J Assoc Physicians India; 2014 Aug; 62(8):749-53. PubMed ID: 25856955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Apoptosis induced by an uromodulin mutant C112Y and its suppression by topiroxostat.
    Utami SB; Mahati E; Li P; Maharani N; Ikeda N; Bahrudin U; Munemura C; Hosoyamada M; Yamamoto Y; Yoshida A; Nakayama Y; Higaki K; Nanba E; Ninomiya H; Shirayoshi Y; Ichida K; Yamamoto K; Hosoya T; Hisatome I
    Clin Exp Nephrol; 2015 Aug; 19(4):576-84. PubMed ID: 25239792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Juvenile gout in Taiwan associated with family history and overweight.
    Chen SY; Shen ML
    J Rheumatol; 2007 Nov; 34(11):2308-11. PubMed ID: 17937457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Familial hyperuricemia and renal insufficiency.
    Foreman JW; Yudkoff M
    Child Nephrol Urol; 1990; 10(2):115-8. PubMed ID: 2253250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Historical review of gout and hyperuricemia investigations].
    Nakamura T
    Nihon Rinsho; 2008 Apr; 66(4):624-35. PubMed ID: 18409506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Membrane targeting and secretion of mutant uromodulin in familial juvenile hyperuricemic nephropathy.
    Jennings P; Aydin S; Kotanko P; Lechner J; Lhotta K; Williams S; Thakker RV; Pfaller W
    J Am Soc Nephrol; 2007 Jan; 18(1):264-73. PubMed ID: 17151335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Urolithiasis in gout and hyperuricemic syndrome].
    Vachtenheim J; Srámek F
    Beitr Rheumatol; 1972; 18():56-60. PubMed ID: 4649119
    [No Abstract]   [Full Text] [Related]  

  • 48. [Molecular genetic mechanisms of the pathogenesis of gout and gouty nephropathy].
    Filippova VG; Popova LA; Chekova VV; L'vova GN; Vasil'eva IM
    Ter Arkh; 1987; 59(8):72-6. PubMed ID: 3686449
    [No Abstract]   [Full Text] [Related]  

  • 49. Genetic Background of a Juvenile Onset Gout Patient.
    Zhang Y; Yin Y; Liu W; Zeng XJ
    Chin Med J (Engl); 2018 Aug; 131(16):2015-2016. PubMed ID: 30082538
    [No Abstract]   [Full Text] [Related]  

  • 50. Functional consequences of a novel uromodulin mutation in a family with familial juvenile hyperuricaemic nephropathy.
    Tinschert S; Ruf N; Bernascone I; Sacherer K; Lamorte G; Neumayer HH; Nürnberg P; Luft FC; Rampoldi L
    Nephrol Dial Transplant; 2004 Dec; 19(12):3150-4. PubMed ID: 15575003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence for a role of uromodulin in chronic kidney disease progression.
    Prajczer S; Heidenreich U; Pfaller W; Kotanko P; Lhotta K; Jennings P
    Nephrol Dial Transplant; 2010 Jun; 25(6):1896-903. PubMed ID: 20075439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autosomal dominant mutation in the signal peptide of renin in a kindred with anemia, hyperuricemia, and CKD.
    Beck BB; Trachtman H; Gitman M; Miller I; Sayer JA; Pannes A; Baasner A; Hildebrandt F; Wolf MT
    Am J Kidney Dis; 2011 Nov; 58(5):821-5. PubMed ID: 21903317
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Homozygous frameshift mutation in the SLC22A12 gene in a patient with primary gout and high levels of serum uric acid.
    Vázquez-Mellado J; Alvarado-Romano V; Burgos-Vargas R; Jiménez-Vaca AL; Pozo-Molina G; Cuevas-Covarrubias SA
    J Clin Pathol; 2007 Aug; 60(8):947-8. PubMed ID: 17660342
    [No Abstract]   [Full Text] [Related]  

  • 55. [Familial gout and nephropathy in a young woman. Report of one case].
    Badilla A; Rojas C
    Rev Med Chil; 2001 Jun; 129(6):666-70. PubMed ID: 11510209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Familial nephropathy with hyperuricemia and gout.
    Leumann EP; Wegmann W
    Nephron; 1983; 34(1):51-7. PubMed ID: 6855996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Preclinical diagnosis of the familial nephropathy associated to hyperuricemia].
    Torres R; Martínez Ara J; Mora M; García Puig J
    Nefrologia; 2006; 26(3):382-6. PubMed ID: 16892829
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does renal impairment protect from gout?
    Youssef P; Brama T; York H; Pickard P; Stewart P; McGill N
    J Rheumatol; 1995 Mar; 22(3):494-6. PubMed ID: 7783068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent insights into kidney diseases associated with glomerular cysts.
    Woolf AS; Feather SA; Bingham C
    Pediatr Nephrol; 2002 Apr; 17(4):229-35. PubMed ID: 11956871
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emergence of Talanin protein associated with human uric acid nephrolithiasis in the Hominidae lineage.
    Gianfrancesco F; Esposito T; Casu G; Maninchedda G; Roberto R; Pirastu M
    Gene; 2004 Sep; 339():131-8. PubMed ID: 15363853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.